Breathing disorders during sleep in myasthenia gravis

Area of Science:

• Neurology
• Pulmonology
• Sleep Medicine

Background:

• Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease.
• Respiratory muscle weakness is a common manifestation of MG.
• Sleep disturbances are frequently reported in MG patients, but their respiratory correlates are not fully understood.

Purpose of the Study:

• To investigate the prevalence and characteristics of sleep-disordered breathing in treated myasthenia gravis patients.
• To identify clinical and physiological predictors of respiratory disturbances during sleep in this population.

Main Methods:

• Prospective study of 20 consecutive MG patients undergoing clinical evaluation (BMI, airway anatomy, functional capacity) and pulmonary function tests.
• Measurement of maximal static inspiratory pressure, transdiaphragmatic pressure, and arterial blood gases.
• Polygraphic sleep monitoring assessing respiration and oxygen saturation.

Main Results:

• All patients demonstrated daytime diaphragmatic weakness, irrespective of functional capacity.
• Older patients with higher BMI, abnormal lung capacity, and abnormal daytime blood gases were more prone to sleep apnea, hypopnea, and nocturnal oxygen desaturation (<90%).
• Sleep-related complaints and rapid-eye-movement sleep were associated with increased breathing vulnerability.

Conclusions:

• Diaphragmatic weakness is a consistent finding in treated MG patients.
• Specific clinical factors can help identify MG patients at risk for sleep-disordered breathing.
• Sleep monitoring is crucial for assessing respiratory compromise in MG, especially during REM sleep.